Ultrasound Evaluation of Cardiac Function During Spontaneous Breathing Trials

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Régional d'Orléans

About this trial

The goal of this clinical trial is to evaluate the evolution of a cardiac ultrasound index (E/E') during 3 spontaneous breathing trials in Intensive Care Unit (ICU) adults (over 18 years) patients at risk for weaning failure. The main objective is to find out which spontaneous breathing trial is the least demanding in terms of heart work.

Investigators will compare 3 consecutive spontaneous breathing trials in a random order to see if one is superior to the others.

Participants will not have to perform any specific procedure apart from breathing without respiratory support during the spontaneous breathing trial. During these trials, the investigator will perform cardiac ultrasound measurements.

Eligibility criteria

Qualifiers

Intubated patient undergoing invasive mechanical ventilation for at least 24 hours and scheduled for a spontaneous breathing trial

Richmond Agitation Sedation Scale (RASS) between -1 and +1

Underlying cardiac disease (left ventricular dysfunction with left ventricular ejection fraction ≤ 45%, documented ischemic heart disease, chronic atrial fibrillation, known history of cardiogenic pulmonary edema)

Underlying respiratory disease (COPD, Emphysema, bronchial dilatation, asthma, obesity/hypoventilation syndrome, restrictive lung disease)

Disqualifiers

Neuromuscular pathology (myasthenia type) preceding hospitalization

Pregnant or breast-feeding women

Patient already included in the study

Protected person (under guardianship or curatorship)

Trial design

Treatments tested in this trial

  • No Pressure Support No Positive End Expiratory Pressure Spontaneous Breathing Trial
  • Pressure Support Spontaneous Breathing trial
  • Humidified High Flow Spontaneous Breathing Trial

Treatment groups

24 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.